Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers.
作者信息
Olsen Jeffrey R, Apisarnthanarax Smith, Murphy James D, Tait Diana, Huguet Florence, Hallemeier Christopher L, Jabbour Salma K
出版信息
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):1-10. doi: 10.1016/j.ijrobp.2019.04.037.
Abstract
摘要
相似文献
1
Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers.胃肠道癌症：优化直肠癌、食管癌和胰腺癌的管理
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):1-10. doi: 10.1016/j.ijrobp.2019.04.037.
2
[Practice-changing clinical trials in gastrointestinal radiation oncology].[胃肠放射肿瘤学中改变实践的临床试验]
Cancer Radiother. 2024 Nov;28(6-7):519-522. doi: 10.1016/j.canrad.2024.09.004. Epub 2024 Oct 18.
3
Radiotherapy in the management of rare gastrointestinal cancers: A systematic review.放射治疗在罕见胃肠道癌症治疗中的应用：系统评价。
Cancer Radiother. 2023 Sep;27(6-7):622-637. doi: 10.1016/j.canrad.2023.06.010. Epub 2023 Jul 25.
4
Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers.
Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):1-9. doi: 10.1016/j.ijrobp.2018.12.052.
5
Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy.病理治疗反应对接受新辅助化疗或放化疗的胰腺癌患者具有不同的预后意义。
Surgery. 2022 May;171(5):1379-1387. doi: 10.1016/j.surg.2021.10.015. Epub 2021 Nov 10.
6
Adjuvant therapy for noncolorectal cancers.非结直肠癌的辅助治疗。
Curr Opin Oncol. 2001 Jul;13(4):287-90. doi: 10.1097/00001622-200107000-00012.
7
Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy?新辅助治疗胰腺腺癌：放化疗还是立体定向体部放射治疗？
Cancer Radiother. 2022 Oct;26(6-7):858-864. doi: 10.1016/j.canrad.2022.06.020. Epub 2022 Aug 17.
8
[Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].程序性死亡蛋白1（PD-1）抗体联合全新辅助放化疗治疗具有高危因素的局部进展期中低位直肠癌的短期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Nov 25;24(11):998-1007. doi: 10.3760/cma.j.cn441530-20210927-00386.
9
FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre.基于 FOLFIRINOX 的新辅助放化疗治疗交界性和局部进展期胰腺癌：来自一家三级中心的初步研究。
Dig Liver Dis. 2019 Jul;51(7):1043-1049. doi: 10.1016/j.dld.2019.03.004. Epub 2019 Apr 15.
10
[Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].[新辅助放化疗还是化疗用于局部晚期食管癌？]
Chirurg. 2020 May;91(5):379-383. doi: 10.1007/s00104-020-01150-6.
引用本文的文献
1
TRP Channels in Digestive Tract Cancers.TRP 通道在消化道癌症中的作用。
Int J Mol Sci. 2020 Mar 9;21(5):1877. doi: 10.3390/ijms21051877.
本文引用的文献
1
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.食管和胃食管交界处癌，2019 年第 2 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.
2
To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality of life questionnaires?低位前切除综合征（LARS）在多大程度上与生活质量相关，这可以通过使用 EORTC C30 和 CR38 生活质量问卷来衡量？
Int J Colorectal Dis. 2019 Apr;34(4):747-762. doi: 10.1007/s00384-019-03249-7. Epub 2019 Feb 5.
3
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.新辅助治疗后完全缓解的直肠癌患者采用观察等待策略的评估。
JAMA Oncol. 2019 Apr 1;5(4):e185896. doi: 10.1001/jamaoncol.2018.5896. Epub 2019 Apr 11.
4
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.FOLFIRINOX 或吉西他滨作为胰腺癌的辅助治疗。
N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.
5
Proton beam therapy for gastrointestinal cancers: past, present, and future.胃肠道癌症的质子束治疗：过去、现在与未来。
J Gastrointest Oncol. 2018 Oct;9(5):962-971. doi: 10.21037/jgo.2017.11.07.
6
Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.仅新辅助（化疗）放疗联合全直肠系膜切除术不足以预防扩大淋巴结中的侧方局部复发：低位 cT3/4 直肠癌患者多中心侧方淋巴结研究的结果。
J Clin Oncol. 2019 Jan 1;37(1):33-43. doi: 10.1200/JCO.18.00032. Epub 2018 Nov 7.
7
Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.保肛经肛门内镜微创手术联合放化疗治疗低位直肠癌的长期肿瘤学及功能学结果：CARTS 研究。
JAMA Surg. 2019 Jan 1;154(1):47-54. doi: 10.1001/jamasurg.2018.3752.
8
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.新辅助放化疗联合手术对比单纯手术治疗局部进展期食管鳞癌（NEOCRTEC5010）：一项 III 期、多中心、随机、开放标签临床试验。
J Clin Oncol. 2018 Sep 20;36(27):2796-2803. doi: 10.1200/JCO.2018.79.1483. Epub 2018 Aug 8.
9
Total neoadjuvant therapy for rectal cancer.直肠癌的全新辅助治疗
Cancer Radiother. 2018 Sep;22(5):459-465. doi: 10.1016/j.canrad.2018.01.004. Epub 2018 May 26.
10
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.FOLFIRINOX 新辅助治疗联合个体化放化疗治疗边界可切除胰腺腺癌：一项 2 期临床试验。
JAMA Oncol. 2018 Jul 1;4(7):963-969. doi: 10.1001/jamaoncol.2018.0329.
Zotero 插件